APIS Breast Cancer Portfolio
Innovative Solutions for Breast Cancer; Advanced Assays with Precise Results
APIS ESR1 Mutations Kit
Wide target coverage – the kit has been designed to cover 11 different ESR1 mutations
High specificity - includes clamp and blocking technology to ensure no wild-type detection
High sensitivity – all mutations are detected at ≤ 1% MAF (Mutant Allele Frequency)
Easy to use – our assays are designed to be user-friendly, with a simple protocol. The reagents have been optimised for precise and sensitive detection in human DNA.
APIS Breast Cancer Subtyping Kit
Detecting HER2, ER, PR & Ki67 mRNA expression with high precision and reproducibility
Single HER2 resolution method, without the need for reflex testing
Novel four-gene signature for measuring proliferation, supporting use of Ki67 alone
Automated results interpretation with APIS software
Opportunity to enhance HER2 stratification